New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO-B)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
279.910.00 (0.00%)
As of 03:59PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close279.91
Open281.55
Bid276.90 x 1400
Ask286.97 x 800
Day's range279.91 - 281.55
52-week range271.00 - 467.95
Volume6
Avg. volume275
Market cap7.882B
Beta (5Y monthly)0.88
PE ratio (TTM)N/A
EPS (TTM)-21.83
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Business Wire

    Bio-Rad Announces Life Science Group Management Changes

    HERCULES, Calif., April 26, 2024--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He succeeds Dr. Simon May, who has announced his decision to leave the company to pursue another professional opportunity.

  • Zacks

    New Strong Sell Stocks for April 19th

    ATNI, ABR and BIO have been added to the Zacks Rank #5 (Strong Sell) List on April 19, 2023.

  • Zacks

    Bio-Rad Laboratories (BIO) to Post Q1 Earnings: What Awaits?

    The ongoing weakness in the biopharma end markets and tightening of sanctions against Russia is likely to have hurt Bio-Rad's (BIO) first-quarter 2024 growth.